These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 17091771

  • 1. Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines.
    Engi H, Sakagami H, Kawase M, Parecha A, Manvar D, Kothari H, Adlakha P, Shah A, Motohashi N, Ocsovszki I, Molnár J.
    In Vivo; 2006; 20(5):637-43. PubMed ID: 17091771
    [Abstract] [Full Text] [Related]

  • 2. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J, Mucsi I, Nacsa J, Hevér A, Gyémánt N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A.
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [Abstract] [Full Text] [Related]

  • 3. MDR-reversal activity of chalcones.
    Ivanova A, Batovska D, Engi H, Parushev S, Ocsovszki I, Kostova I, Molnar J.
    In Vivo; 2008; 22(3):379-84. PubMed ID: 18610751
    [Abstract] [Full Text] [Related]

  • 4. Multidrug resistance reversal by 3-formylchromones in human colon cancer and human mdr1 gene-transfected mouse lymphoma cells.
    Baráth Z, Radics R, Spengler G, Ocsovszki I, Kawase M, Motohashi N, Shirataki Y, Shah A, Molnár J.
    In Vivo; 2006; 20(5):645-9. PubMed ID: 17091772
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of P-glycoprotein transport function by N-acylphenothiazines.
    Wesolowska O, Molnár J, Motohashi N, Michalak K.
    Anticancer Res; 2002; 22(5):2863-7. PubMed ID: 12530010
    [Abstract] [Full Text] [Related]

  • 6. Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
    Pajak B, Molnar J, Engi H, Orzechowski A.
    In Vivo; 2005; 19(6):1101-4. PubMed ID: 16277030
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L, Fouladdel S, Shafiee A, Amini M, Ghaffari SM, Azizi E.
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones.
    Ferreira MJ, Gyémánt N, Madureira AM, Molnár J.
    Anticancer Res; 2005 Apr; 25(5):3259-62. PubMed ID: 16101136
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line.
    Ferreira MJ, Gyémánt N, Madureira AM, Tanaka M, Koós K, Didziapetris R, Molnár J.
    Anticancer Res; 2005 Apr; 25(6B):4173-8. PubMed ID: 16309213
    [Abstract] [Full Text] [Related]

  • 12. Effect of cycloartanes on reversal of multidrug resistance and apoptosis induction on mouse lymphoma cells.
    Madureira AM, Spengler G, Molnár A, Varga A, Molnár J, Abreu PM, Ferreira MJ.
    Anticancer Res; 2004 Apr; 24(2B):859-64. PubMed ID: 15161038
    [Abstract] [Full Text] [Related]

  • 13. Dihydropyridines and atypical MDR: a novel perspective of designing general reversal agents for both typical and atypical MDR.
    Miri R, Mehdipour A.
    Bioorg Med Chem; 2008 Sep 15; 16(18):8329-34. PubMed ID: 18701304
    [Abstract] [Full Text] [Related]

  • 14. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X, Sun B, Zhu CJ, Yuan HQ, Shi YQ, Gao J, Li SJ, Lou HX.
    Toxicol In Vitro; 2009 Feb 15; 23(1):29-36. PubMed ID: 18938236
    [Abstract] [Full Text] [Related]

  • 15. Toxoplasma infection and cell free extract of the parasites are able to reverse multidrug resistance of mouse lymphoma and human gastric cancer cells in vitro.
    Varga A, Sokolowska-Kohler W, Presber W, Von Baehr V, Von Baehr R, Lucius R, Volk D, Nacsa J, Hever A.
    Anticancer Res; 1999 Feb 15; 19(2A):1317-24. PubMed ID: 10368693
    [Abstract] [Full Text] [Related]

  • 16. Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors.
    Voigt B, Coburger C, Monár J, Hilgeroth A.
    Bioorg Med Chem; 2007 Aug 01; 15(15):5110-3. PubMed ID: 17533131
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
    Hasegawa T, Bai J, Dai J, Bai L, Sakai J, Nishizawa S, Bai Y, Kikuchi M, Abe M, Yamori T, Tomida A, Tsuruo T, Hirose K, Ando M.
    Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3722-8. PubMed ID: 17490878
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
    Huang L, Wang C, Zheng W, Liu R, Yang J, Tang C.
    Anticancer Drugs; 2007 Oct 01; 18(9):1075-80. PubMed ID: 17704658
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.